Literature DB >> 12043288

[Reproducibility of measuring retinal nerve fiber density. Comparison of optical coherence tomography with the nerve fiber analyzer and the Heidelberg retinal tomography device].

M Klemm1, E Rumberger, A Walter, G Richard.   

Abstract

BACKGROUND: Glaucoma is associated with a progressive loss of retinal ganglion cell axons and the evaluation of the thickness of the retinal nerve fibre layer (RNFL) is important for early diagnosis and follow-up. Results of RNFL thickness measurements may vary according to the devices used. Therefore, the present study has analysed and compared the reproducibility of data obtained with three different instruments.
METHODS: RNFL thickness was determined using a circular identification line around the optic nerve head by optical coherence tomography (OCT), a Heidelberg Retina Tomograph (HRT) and a Nerve Fiber Analyser (NFA). Each eye was tested six times. The values for RNFL thickness were calculated for the superior, inferior, nasal and temporal areas. A one-way analysis of variance with random effects was chosen to estimate the variance components. The intraclass correlation coefficient (ICC) as a measure of reliability and the coefficient of variation (CV%) as a measure of precision were determined to estimate the reproducibility of RNFL thickness measurements.
RESULTS: With all three instruments, the reproducibility of measurements between the superior, inferior, temporal and nasal areas did not differ significantly suggesting that reproducibility does not depend on the thickness of the RNFL. Data obtained by NFA showed the highest ICC values (0.9) and lowest CV% values (7.0), followed by those obtained by HRT (reliability ICC 0.8; precision CV% 12). A markedly lower degree of reproducibility was found for the OCT compared to NFA and HRT (reliability ICC 0.5; precision CV% 15).
CONCLUSION: The comparison of RNFL thickness measurements with OCT, NFA, and HRT showed that the NFA yielded the most reliable results followed by HRT.

Entities:  

Mesh:

Year:  2002        PMID: 12043288     DOI: 10.1007/s00347-001-0556-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

1.  [Reproducibility of goniometry with slitlamp-adapted optical coherence tomography].

Authors:  A Karandish; C Wirbelauer; H Häberle; D T Pham
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  Sources of longitudinal variability in optical coherence tomography nerve-fibre layer measurements.

Authors:  L Kagemann; T Mumcuoglu; G Wollstein; R Bilonick; H Ishikawa; K A Townsend; M Gabriele; J G Fujimoto; J S Schuman
Journal:  Br J Ophthalmol       Date:  2008-06       Impact factor: 4.638

3.  Epiretinal membrane as a source of errors during the measurement of peripapillary nerve fibre thickness using spectral-domain optical coherence tomography (SD-OCT).

Authors:  Florian Rüfer; Julia Jasmin Bartsch; Carl Erb; Anneliese Riehl; Philipp Franko Zeitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-27       Impact factor: 3.117

4.  Effect of glaucomatous damage on repeatability of confocal scanning laser ophthalmoscope, scanning laser polarimetry, and optical coherence tomography.

Authors:  Julio E DeLeón Ortega; Lisandro M Sakata; Bobby Kakati; Gerald McGwin; Blythe E Monheit; Stella N Arthur; Christopher A Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

5.  [Reproducibility of measurements of the peripapillary retinal nerve fibre layer thickness. Optical coherence tomography versus retinal thickness analyzer].

Authors:  R Krist; E M Hoffmann; O Schwenn
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

6.  Improved reproducibility of retinal nerve fiber layer thickness measurements with the repeat-scan protocol using the Stratus OCT in normal and glaucomatous eyes.

Authors:  Argyrios Tzamalis; Myron Kynigopoulos; Torsten Schlote; Ivan Haefliger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-23       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.